- Cancer Care Team
Cancer Care Team
To deliver optimal patient outcomesProducts and Services
Cancer Type
Supplies & Tools
Scientific Focus
- Biopharma Partners
- Patients
- Education & Events
- Login
- Contact Us
Event

October 25-29, 2025
We are empowering providers and patients with meaningful health data to pave the way for new treatments, targeted therapies and individualized healthcare.
Meet our team at booth 2137 to discover how we’re streamlining reproductive testing to support successful fertility outcomes.
Join us for a conversation to learn about:
Clinical Session
Speaker: Dana Neitzel, MS, CGC, Director of Product Management, Carrier Screening and Rare Disease
Location: 007 CD, River Level
Carrier screening (CS) has become an almost ubiquitous test in the journey of a fertility patient in the United States. CS panels and labs that offer them are in a constant state of flux, with labs and tested genes appearing and disappearing.
With this flux, we have seen debate on the appropriateness of testing certain genes and reporting certain variants, the benefits (or lack thereof) of expanding panels with less common conditions, and the evidence labs use to justify reporting “carrier risks.”
This session seeks to continue discussion around these questions to explore what constitutes the most useful and effective CS.
Genetics Poster Session
Speaker: Erin Rooney, MS, CGC, Principal Genetic Counselor
Location: Poster Hall Station 16, Meeting Level
Attend our poster session featuring new data revealing that over 60% of donor-recipient pairings in our study show genetic carrier screening discrepancies—most commonly with sperm donors. This research underscores the importance of reviewing donor screening results against recipient profiles and points to a need for increased recipient education in the donor selection process.
Genetics Poster Session
Speaker: Jillian Carroll, MS, CGC, Principal Genetic Counselor
Location: Poster Hall Station 2, Meeting Level
Attend our poster session featuring a new study exploring how recipients respond to carrier screening discrepancies between gamete donors and intended genetic parents. Findings show a clear trend: recipients are significantly more likely to elect for additional testing on themselves than on prospective donors. This study addresses the importance of genetic counseling in guiding informed decisions.